Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy Type 1 (NT1)”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Looking for participantsNCT07455383
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 150
Not applicableLooking for participantsNCT07006233
What this trial is testing

A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Idiopathic HypersomniaNarcolepsy Type 1 (NT 1)Narcolepsy Type 2 (NT2)
University of Sydney 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07625280
What this trial is testing

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

Who this might be right for
NarcolepsyIdiopathic Hypersomnia
Jazz Pharmaceuticals 108
Large-scale testing (Phase 3)Looking for participantsNCT06767683
What this trial is testing

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Alkermes, Inc. 256
Large-scale testing (Phase 3)Looking for participantsNCT07540897
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT07096674
What this trial is testing

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited 90
Early research (Phase 1)Study completedNCT06462404
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1 (NT1)
Eisai Inc. 22
Testing effectiveness (Phase 2)Looking for participantsNCT06809803
What this trial is testing

Extended-release Sodium Oxybate in Children

Who this might be right for
Narcolepsy Type 1 (NT 1)
Stanford University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07633301
What this trial is testing

TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

Who this might be right for
Narcolepsy Type 1
Takeda 92
Testing effectiveness (Phase 2)Looking for participantsNCT07493265
What this trial is testing

Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Who this might be right for
Narcolepsy
Eisai Inc. 64
Early research (Phase 1)Looking for participantsNCT07584434
What this trial is testing

A Phase 1, First-in-human Study of VX-433

Who this might be right for
Narcolepsy Type 1 (NT1)
Vertex Pharmaceuticals Incorporated 118
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Testing effectiveness (Phase 2)Ended earlyNCT04096560
What this trial is testing

TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)
Takeda 97
Large-scale testing (Phase 3)Looking for participantsNCT07598708
What this trial is testing

Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited 222
Large-scale testing (Phase 3)Looking for participantsNCT07363720
What this trial is testing

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy With Cataplexy
Takeda 88
Not applicableStudy completedNCT04445129
What this trial is testing

Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants

Who this might be right for
Healthy VolunteersNarcolepsy Type 1
Takeda 45